(2R,4S)-4-((tert-Butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 95.0%, 250mg

1-Butyl-3-methylimidazolium hydroxide, 70%, 100g

6-Chloro-4-hydroxy-2-methyl-N-pyridin-2-yl-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide (Lornoxicam), 97.0%, 250mg

Ethyl 4-(3-chlorophenyl)-3-oxobutanoate, 95.0%, 2g

(S)-(3-Aminopyrrolidin-1-yl)(pyridin-3-yl)methanone dihydrochloride, 1g

3-(4-(3-(Trifluoromethyl)-3H-diazirin-3-yl)phenyl)propanoic acid, 97%, 1g

tert-Butyl 3-Benzylpiperazine-1-carboxylate, 97.0%, 10g

4-((Tetrahydro-2H-pyran-4-yl)amino)butan-1-ol, 97%, 250mg

4-(2-Methoxyphenoxy)aniline, 98.0%, 5g

(2E)-1-(3,4-dichlorophenyl)-3-(furan-2-yl)prop-2-en-1-one, 95.0%, 2g

1-(3-phenylisoxazol-5-yl)methanamine, 95.0%, 2.5g

3-Hydroxypyrrolidine-1-carboximidamide sulfate, 95.0%, 250mg

Density standard, ROTI®Calipure, 1.0792 g/ml (20 °C), 100 ml, glass packaging